Lysteda
Jeneng umum: Tranexamic Acid (Lysteda)
Kelas obat:
Aneka modifikasi koagulasi
Panganggone Lysteda
Lysteda minangka wujud asam amino (protein) sing diarani lisin. Asam traneksamat nyegah enzim ing awak ngrusak gumpalan getih.
Lysteda digunakake kanggo nambani pendarahan menstruasi sing abot. Obat iki ora bakal nambani sindrom pramenstruasi (PMS).
Lysteda uga bisa digunakake kanggo tujuan sing ora kadhaptar ing pandhuan pengobatan iki.
Lysteda efek sisih
Njaluk bantuan medis darurat yen sampeyan duwe tandha-tandha reaksi alergi marang Lysteda: gatal-gatal; kangelan ambegan; bengkak ing pasuryan, lambe, ilat, utawa tenggorokan.
Stop njupuk Lysteda lan langsung hubungi dhokter yen sampeyan duwe efek samping sing serius kayata:
Efek samping Lysteda sing kurang serius kalebu:
Iki dudu dhaptar lengkap efek samping lan liya-liyane bisa uga. dumadi. Telpon dhokter kanggo saran medis babagan efek samping. Sampeyan bisa nglaporake efek samping menyang FDA ing 1-800-FDA-1088.
Sadurunge njupuk Lysteda
Sampeyan ora kudu njupuk Lysteda yen sampeyan alergi marang asam traneksamat, utawa yen sampeyan duwe:
Kanggo mesthekake sampeyan bisa njupuk Lysteda kanthi aman, hubungi dhokter yen sampeyan duwe kondisi liyane:
Ora dingerteni apa Lysteda bakal ngrusak bayi sing durung lair. Marang dhokter sampeyan yen sampeyan lagi ngandhut utawa rencana bakal ngandhut nalika nggunakake Lysteda. Asam traneksamat bisa mlebu ing susu ibu lan bisa ngrusak bayi sing lagi nyusoni. Aja nggunakake Lysteda tanpa ngandhani dhokter yen sampeyan lagi nyusoni bayi. Aja menehi obat iki kanggo sapa wae ing umur 18 taun tanpa saran dhokter. Aja nuduhake Lysteda karo wong liya, sanajan dheweke duwe gejala sing padha.
Related obat
- Advate
- Adynovate
- Adynovate recombinant
- Afstyla
- Afstyla recombinant
- Agrylin
- Alphanate
- Alphanine SD
- Alprolix
- Alprolix (Factor ix fc fusion protein recombinant Intravenous)
- Altuviiio
- Altuviiio (Antihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl Intravenous)
- Altuviiio (Antihemophilic factor Intravenous)
- Amicar
- Amicar (Aminocaproic acid Intravenous)
- Amicar (Aminocaproic acid Oral)
- Aminocaproic acid
- Aminocaproic acid (Intravenous)
- Aminocaproic acid (Oral)
- Anagrelide
- Anti-inhibitor coagulant complex
- Antihemophilic and von Willebrand factor complex
- Antihemophilic factor
- Antihemophilic factor (recombinant) pegylated-aucl
- Antihemophilic factor (recombinant) porcine sequence
- Antihemophilic factor (recombinant), fc-vwf-xten fusion protein-ehtl
- Antihemophilic factor (recombinant), glycopegylated-exei
- Antihemophilic factor human
- Antihemophilic factor recombinant
- Antihemophilic factor viii and von willebrand factor
- Artiss
- Artiss Duo Set
- Artiss Duploject
- Autoplex T
- Coagadex
- Coagulation factor IX
- Coagulation factor ix recombinant
- Coagulation factor ix recombinant, glycopegylated
- Coagulation factor viia
- Coagulation factor VIIa injection
- Coagulation factor viia-jncw
- Coagulation factor X
- Corifact
- Cyklokapron
- Bebulin VH
- BeneFIX
- Benefix (Coagulation factor ix recombinant Intravenous)
- Ceprotin
- Defibrotide
- Defitelio
- Eloctate
- Eloctate with Fc Fusion Protein recombinant
- Emicizumab
- Emicizumab-kxwh
- Esperoct (Antihemophilic factor (recombinant), glycopegylated-exei Intravenous)
- Esperoct (Antihemophilic factor Intravenous)
- Esperoct recombinant
- Evarrest
- Factor ix albumin fusion protein recombinant
- Factor IX complex
- Factor ix fc fusion protein recombinant
- Factor x human
- Factor XIII
- Feiba VH Immuno
- Feiba-VH
- Fibrin sealant topical
- Fibrinogen
- Fibrinogen and thrombin, human
- Fibrinogen/aprotinin and thrombin/calcium chloride
- Fostamatinib
- Fostamatinib disodium
- Helixate FS
- Helixate FS recombinant
- Hemlibra
- Hemofil-M
- Hemofil-M human
- Humate-P
- Hyate:C
- Idelvion
- Idelvion (Factor ix albumin fusion protein recombinant Intravenous)
- Ixinity
- Ixinity (Coagulation factor ix recombinant Intravenous)
- Jivi (Antihemophilic factor (recombinant) pegylated-aucl Intravenous)
- Jivi (Antihemophilic factor Intravenous)
- Jivi recombinant
- Koate DVI
- Koate-DVI human
- Kogenate FS
- Kogenate FS recombinant
- Kogenate FS with Adapter recombinant
- Kovaltry recombinant
- Lysteda
- Monoclate-P human
- Mononine
- Novoeight recombinant
- Novoseven
- NovoSeven RT
- NovoSeven RT with MixPro injection
- Nuwiq recombinant
- Obizur (Antihemophilic factor (recombinant) porcine sequence Intravenous)
- Obizur (Antihemophilic factor Intravenous)
- Pentopak
- Pentoxifylline
- Pentoxil
- Protein c, human
- Raplixa
- Rebinyn
- Rebinyn (Coagulation factor ix recombinant, glycopegylated Intravenous)
- Recombinate recombinant
- RiaSTAP
- Rixubis
- Rixubis (Coagulation factor ix recombinant Intravenous)
- Roctavian
- Tachosil
- Tavalisse
- Thrombin human, recombinant
- Tisseel
- Tisseel Duploject Kit
- Tisseel Valupak Kit
- Tranexamic acid
- Tranexamic acid (Intravenous)
- Tranexamic acid (Oral)
- Tranexamic acid Lysteda
- Trental
- Tretten
- Valoctocogene roxaparvovec-rvox
- Von Willebrand factor recombinant
- Vonvendi
- Wilate
- Xyntha
Carane nggunakake Lysteda
Njupuk Lysteda persis kaya sing diresepake dening dokter. Aja njupuk jumlah sing luwih gedhe utawa luwih cilik utawa luwih suwe tinimbang sing disaranake. Tindakake pituduh ing label resep sampeyan.
Aja miwiti njupuk Lysteda nganti sampeyan wis haid. Aja njupuk luwih saka 5 dina saurutan.
Lysteda biasane dijupuk kaping telu saben dina nganti 5 dina sajrone menstruasi. Aja njupuk luwih saka 6 tablet sajrone wektu 24 jam.
Entuk Lysteda kanthi segelas banyu kebak.
Sampeyan bisa njupuk asam traneksamat kanthi utawa tanpa panganan.
Aja ngremuk, ngunyah, utawa ngrusak tablet Lysteda. Telan kabeh.
Rembugan karo dhokter yen gejala sampeyan ora saya tambah sawise 2 siklus perawatan.
Simpen Lysteda ing suhu kamar adoh saka kelembapan lan panas.
Pènget
Sampeyan ora kudu nggunakake Lysteda yen sampeyan alergi marang asam traneksamat, yen sampeyan duwe masalah karo pembuluh getih ing mripat, utawa yen sampeyan nate ngalami stroke, gumpalan getih, utawa getihen ing otak.
Sadurungé nggunakake Lysteda, takon dhokter sampeyan yen sampeyan duwe penyakit ginjel, leukemia, riwayat endometriosis, utawa yen siklus menstruasi kurang saka 21 dina utawa luwih saka 35 dina.
Aja miwiti njupuk Lysteda nganti haid diwiwiti. Aja njupuk luwih saka 5 dina saurutan. Dhiskusi karo dhokter yen gejala sampeyan ora saya apik sawise 2 siklus perawatan.
Aja njupuk luwih saka 6 tablet sajrone wektu 24 jam.
Gunakake wangun penghalang lair. kontrol (kayata kondom utawa diafragma karo spermisida). Kontrasepsi hormonal (kayata pil KB, injeksi, implan, tambalan kulit, lan cincin vagina) bisa nambah risiko stroke, bekuan getih, utawa serangan jantung yen digunakake bebarengan karo Lysteda. Aja nuduhake Lysteda karo wong liya, sanajan dheweke duwe gejala sing padha.
Apa obatan liyane bakal mengaruhi Lysteda
Marang dhokter sampeyan babagan kabeh obat liyane sing sampeyan gunakake, utamane:
Iki dhaftar ora lengkap lan obatan liyane bisa sesambungan karo Lysteda. Marang dhokter sampeyan babagan kabeh obat sing sampeyan gunakake. Iki kalebu resep, over-the-counter, vitamin, lan produk herbal. Aja miwiti obat anyar tanpa ngandhani dhokter sampeyan.
Disclaimer
Kabeh upaya wis ditindakake kanggo mesthekake yen informasi sing diwenehake dening Drugslib.com akurat, nganti -tanggal, lan lengkap, nanging ora njamin kanggo efek sing. Informasi obat sing ana ing kene bisa uga sensitif wektu. Informasi Drugslib.com wis diklumpukake kanggo digunakake dening praktisi kesehatan lan konsumen ing Amerika Serikat lan mulane Drugslib.com ora njamin sing nggunakake njaba Amerika Serikat cocok, kajaba khusus dituduhake digunakake. Informasi obat Drugslib.com ora nyetujoni obat, diagnosa pasien utawa menehi rekomendasi terapi. Informasi obat Drugslib.com minangka sumber informasi sing dirancang kanggo mbantu praktisi kesehatan sing dilisensi kanggo ngrawat pasien lan / utawa nglayani konsumen sing ndeleng layanan iki minangka tambahan, lan dudu pengganti, keahlian, katrampilan, kawruh lan pertimbangan babagan perawatan kesehatan. praktisi.
Ora ana bebaya kanggo kombinasi obat utawa obat sing diwenehake kanthi cara apa wae kudu ditafsirake kanggo nuduhake yen obat utawa kombinasi obat kasebut aman, efektif utawa cocok kanggo pasien tartamtu. Drugslib.com ora nanggung tanggung jawab kanggo aspek kesehatan apa wae sing ditindakake kanthi bantuan informasi sing diwenehake Drugslib.com. Informasi sing ana ing kene ora dimaksudake kanggo nyakup kabeh panggunaan, pituduh, pancegahan, bebaya, interaksi obat, reaksi alergi, utawa efek samping. Yen sampeyan duwe pitakon babagan obat sing sampeyan gunakake, takon dhokter, perawat utawa apoteker.
Tembung kunci populer
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions